Pricing Log in Create free account

Climb Bio, Inc. (CLYM) vs SL SCIENCE HLDG (SLBT)

Climb Bio, Inc. and SL SCIENCE HLDG are both Biotechnology companies. Climb Bio, Inc. and SL SCIENCE HLDG are of similar size ($509.5M and $504.7M). Across the 2 metrics below, Climb Bio, Inc. leads on 1 and SL SCIENCE HLDG on 1.

Valuation

Metric CLYM SLBT Biotechnology median
P/E n/m — 10.60
P/S n/m — 9.40
P/B 3.27 n/m 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (8.07%) — (32.88%)
Free cash flow yield (6.79%) — (23.13%)

Profitability

Metric CLYM SLBT Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (27.10%) — (51.96%)
Return on assets (26.27%) — (46.06%)
Return on invested capital (71.73%) 0.00% 0.00%

Growth

Metric CLYM SLBT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 42.48% — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CLYM SLBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.45 4.44 4.97
Net debt to EBITDA 1.44 — 1.01

Dividend

Metric CLYM SLBT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLYM SLBT Biotechnology median
Market cap 509.46m 504.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack